Evidence map›Paper›PMID 37812771›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2023

The role of health system penetration rate in estimating the prevalence of type 1 diabetes in children and adolescents using electronic health records.

Piaopiao Li, Tianchen Lyu, Khalid Alkhuzam, Eliot Spector, William T Donahoo, Sarah Bost, Yonghui Wu, William R Hogan, Mattia Prosperi, Desmond A Schatz and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Piaopiao LiDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States.
Tianchen LyuDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States.
Khalid AlkhuzamDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States.
Eliot SpectorDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States.
William T DonahooDivision of Endocrinology, Diabetes & Metabolism, College of Medicine, University of Florida, Gainesville, FL, United States.
Sarah BostDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States.
Yonghui WuDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States.ORCID 0000-0002-6780-6135
William R HoganDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States.ORCID 0000-0002-9881-1017
Mattia ProsperiDepartment of Epidemiology, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States.ORCID 0000-0002-9021-5595
Desmond A SchatzDepartment of Pediatrics, College of Medicine, University of Florida, Gainesville, FL, United States.
Mark A AtkinsonDiabetes Institute, University of Florida, Gainesville, FL, United States.
Michael J HallerDepartment of Pediatrics, College of Medicine, University of Florida, Gainesville, FL, United States.
Elizabeth A ShenkmanDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States.
Yi GuoDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States.ORCID 0000-0003-0587-4105
Jiang BianDepartment of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States.ORCID 0000-0002-2238-5429
Hui ShaoDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States.ORCID 0000-0002-4088-546X
University of Florida · USCenter for Drug Evaluation and Research · USEmory University · US

Funding

Supplement of NIDDK R01 newer GLDs and Clinical OutcomesR01DK133465 · NIDDK · UNIVERSITY OF FLORIDA · PI GUO, JINGCHUAN, SHAO, HUI · 2022 to 2025
$2.8M
Using Real-world Data to Assess the Burden of Diabetes in Children and Adolescents in FloridaU18DP006512 · DP · UNIVERSITY OF FLORIDA · PI BIAN, JIANG, GUO, YI · 2020 to 2024
$1.4M
NCCDPHP CDC HHS U18 DP006512NIDDK NIH HHS R01 DK133465NIDDK NIH HHS U18DP006512
6 · The paper itself

Abstract

objectiveHaving sufficient population coverage from the electronic health records (EHRs)-connected health system is essential for building a comprehensive EHR-based diabetes surveillance system. This study aimed to establish an EHR-based type 1 diabetes (T1D) surveillance system for children and adolescents across racial and ethnic groups by identifying the minimum population coverage from EHR-connected health systems to accurately estimate T1D prevalence. MATERIALS AND

methodsWe conducted a retrospective, cross-sectional analysis involving children and adolescents <20 years old identified from the OneFlorida+ Clinical Research Network (2018-2020). T1D cases were identified using a previously validated computable phenotyping algorithm. The T1D prevalence for each ZIP Code Tabulation Area (ZCTA, 5 digits), defined as the number of T1D cases divided by the total number of residents in the corresponding ZCTA, was calculated. Population coverage for each ZCTA was measured using observed health system penetration rates (HSPR), which was calculated as the ratio of residents in the corresponding ZTCA and captured by OneFlorida+ to the overall population in the same ZCTA reported by the Census. We used a recursive partitioning algorithm to identify the minimum required observed HSPR to estimate T1D prevalence and compare our estimate with the reported T1D prevalence from the SEARCH study.

resultsObserved HSPRs of 55%, 55%, and 60% were identified as the minimum thresholds for the non-Hispanic White, non-Hispanic Black, and Hispanic populations. The estimated T1D prevalence for non-Hispanic White and non-Hispanic Black were 2.87 and 2.29 per 1000 youth, which are comparable to the reference study's estimation. The estimated prevalence of T1D for Hispanics (2.76 per 1000 youth) was higher than the reference study's estimation (1.48-1.64 per 1000 youth). The standardized T1D prevalence in the overall Florida population was 2.81 per 1000 youth in 2019.

conclusionOur study provides a method to estimate T1D prevalence in children and adolescents using EHRs and reports the estimated HSPRs and prevalence of T1D for different race and ethnicity groups to facilitate EHR-based diabetes surveillance.

Indexed as

Diabetes Mellitus, Type 1AdolescentAdultChildCross-Sectional StudiesElectronic Health RecordsHumansPrevalenceRetrospective StudiesYoung Adultchildren and adolescentdisease surveillanceelectronic health recordshealth system penetration rateprevalencetype 1 diabetes

Identifiers

PMID37812771
PMCPMC10746308
OpenAlexW4387446333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.